Constraint. We have a very powerful pipeline. Preps for phase 3 on Brilacidin, meetings with BP, FDA and a lot of scientific mumbo jumbo. Kevetrin -OC trial coming to and end and all that work ahead. Prurisol data compilation and next steps to show it off and possibly sell it. Why spend money on bs if you don't have to?

Leo has to be one of the best penny pinchers I've ever known.

The share structure and how far we've come atones to that.

He's got our backs.

So really, other than Menon cutting his pay for a bit, nothing new.

$IPIX